Earnings call: REGENXBIO unveils strategic plan, positive clinical data, and corporate restructuring By Investing.com

[ad_1] In their third quarter 2023 earnings call, biotechnology company REGENXBIO announced an updated strategic plan, positive clinical data from priority programs, and a corporate restructuring plan. The company is…